Tetsuya Sugiyama

1.9k citations
60 papers · 1.6k indexed · h-index 24

Tetsuya Sugiyama

60 papers receiving 1.5k citations

Peers

Tetsuya Sugiyama
Comparison fields: 5 of 86
  • Ophthalmology 631
  • Physiology 311
  • Neurology 251
  • Endocrine and Autonomic Systems 111
  • Clinical Biochemistry 103
Replace Hidehiro Oku with:
Hidehiro Oku Japan
Agata Grazia D’Amico Italy
Christine Altmann Germany
Vijay P. Sarthy United States
Ping Hu Australia
Yasushi Kitaoka Japan
C. Henrique Alves Netherlands
Ashay D. Bhatwadekar United States
Elena Ivanova United States
Priya Chaudhary United States
Tetsuya Sugiyama relative to Hidehiro Oku Japan Hidehiro Oku's profile →
Citations per field
00.5×2.6×
Hidehiro Oku · 1×
Citations per year

Countries citing papers authored by Tetsuya Sugiyama

Since Specialization
Citations

This map shows the geographic impact of Tetsuya Sugiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Sugiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Sugiyama more than expected).

Fields of papers citing papers by Tetsuya Sugiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Sugiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Sugiyama. The network helps show where Tetsuya Sugiyama may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tetsuya Sugiyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tetsuya Sugiyama Line = papers co-authored together Tetsuya Sugiyama links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20158
2 20154
3 20146
4 201430
5 201224
6 201120
7 201017
8 20086
9 200751
10 200623
11 200645
12 200550
13 200422
14 200418
15 200458
16 20035
17 200217
18 200121
19 200120
20
Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects.
199960

About Tetsuya Sugiyama

Tetsuya Sugiyama is a scholar working on Ophthalmology, Physiology and Neurology, having authored 60 papers that have together received 1.6k indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (25 papers), Retinal Diseases and Treatments (21 papers), Adenosine and Purinergic Signaling (12 papers), Retinal Development and Disorders (10 papers), Neurological Disorders and Treatments (8 papers), Nitric Oxide and Endothelin Effects (7 papers), Neuroscience of respiration and sleep (7 papers) and Neurological Complications and Syndromes (6 papers). The work is most often cited by research in Ophthalmology (631 citations), Physiology (311 citations) and Neurology (251 citations). Tetsuya Sugiyama has collaborated with scholars based in Japan and United States. Frequent co-authors include Tsunehiko Ikeda, Hidehiro Oku, Donald G. Puro, Hajime Kawamura, Masato Kobayashi, Kozo Katsumura, Shigeki Yamanishi, David M. Wu, Hideaki Hara and Shinji Takai. Their work appears in journals such as Nature Immunology, PLoS ONE and The Journal of Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026